Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 146

Similar articles for PubMed (Select 10492632)

1.

Megestrol acetate in advanced, progressive, hormone-insensitive cancer. Effects on the quality of life: a placebo-controlled, randomised, multicentre trial.

Westman G, Bergman B, Albertsson M, Kadar L, Gustavsson G, Thaning L, Andersson M, Straumits A, Jeppson B, Lindén CJ, Ewers SB, Andersson H, Mercke C, Hafström L, Birck O, Orgum P.

Eur J Cancer. 1999 Apr;35(4):586-95.

PMID:
10492632
2.

Improved quality of life with megestrol acetate in patients with endocrine-insensitive advanced cancer: a randomised placebo-controlled trial. Australasian Megestrol Acetate Cooperative Study Group.

Beller E, Tattersall M, Lumley T, Levi J, Dalley D, Olver I, Page J, Abdi E, Wynne C, Friedlander M, Boadle D, Wheeler H, Margrie S, Simes RJ.

Ann Oncol. 1997 Mar;8(3):277-83.

3.

Megestrol acetate for anorexia in patients with far-advanced cancer: a double-blind controlled clinical trial.

De Conno F, Martini C, Zecca E, Balzarini A, Venturino P, Groff L, Caraceni A.

Eur J Cancer. 1998 Oct;34(11):1705-9.

PMID:
9893656
4.

Supportive use of megestrol acetate (Megace) with head/neck and lung cancer patients receiving radiation therapy.

McQuellon RP, Moose DB, Russell GB, Case LD, Greven K, Stevens M, Shaw EG.

Int J Radiat Oncol Biol Phys. 2002 Apr 1;52(5):1180-5.

PMID:
11955728
5.

Anticachectic efficacy of megestrol acetate at different doses and versus placebo in patients with neoplastic cachexia.

Vadell C, Seguí MA, Giménez-Arnau JM, Morales S, Cirera L, Bestit I, Batiste E, Blanco R, Jolis L, Boleda M, Antón I.

Am J Clin Oncol. 1998 Aug;21(4):347-51.

PMID:
9708631
6.

Usage of megestrol acetate in the treatment of anorexia-cachexia syndrome in the elderly.

Yeh SS, Lovitt S, Schuster MW.

J Nutr Health Aging. 2009 May;13(5):448-54.

PMID:
19390752
7.
8.
9.

Effects of medroxyprogesterone acetate on appetite, weight, and quality of life in advanced-stage non-hormone-sensitive cancer: a placebo-controlled multicenter study.

Simons JP, Aaronson NK, Vansteenkiste JF, ten Velde GP, Muller MJ, Drenth BM, Erdkamp FL, Cobben EG, Schoon EJ, Smeets JB, Schouten HC, Demedts M, Hillen HF, Blijham GH, Wouters EF.

J Clin Oncol. 1996 Apr;14(4):1077-84.

PMID:
8648360
10.

A prospective randomized study of megestrol acetate and ibuprofen in gastrointestinal cancer patients with weight loss.

McMillan DC, Wigmore SJ, Fearon KC, O'Gorman P, Wright CE, McArdle CS.

Br J Cancer. 1999 Feb;79(3-4):495-500.

11.

Supportive use of megestrol acetate in patients with head and neck cancer during radio(chemo)therapy.

Fietkau R, Riepl M, Kettner H, Hinke A, Sauer R.

Eur J Cancer. 1997 Jan;33(1):75-9.

PMID:
9071903
12.

A randomized, double-blind, placebo-controlled clinical trial of megestrol acetate as an appetite stimulant in children with weight loss due to cancer and/or cancer therapy.

Cuvelier GD, Baker TJ, Peddie EF, Casey LM, Lambert PJ, Distefano DS, Wardle MG, Mychajlunow BA, Romanick MA, Dix DB, Wilson BA.

Pediatr Blood Cancer. 2014 Apr;61(4):672-9. doi: 10.1002/pbc.24828. Epub 2013 Oct 26.

PMID:
24167059
13.

An eicosapentaenoic acid supplement versus megestrol acetate versus both for patients with cancer-associated wasting: a North Central Cancer Treatment Group and National Cancer Institute of Canada collaborative effort.

Jatoi A, Rowland K, Loprinzi CL, Sloan JA, Dakhil SR, MacDonald N, Gagnon B, Novotny PJ, Mailliard JA, Bushey TI, Nair S, Christensen B; North Central Cancer Treatment Group.

J Clin Oncol. 2004 Jun 15;22(12):2469-76.

14.
15.
16.

Dronabinol versus megestrol acetate versus combination therapy for cancer-associated anorexia: a North Central Cancer Treatment Group study.

Jatoi A, Windschitl HE, Loprinzi CL, Sloan JA, Dakhil SR, Mailliard JA, Pundaleeka S, Kardinal CG, Fitch TR, Krook JE, Novotny PJ, Christensen B.

J Clin Oncol. 2002 Jan 15;20(2):567-73.

PMID:
11786587
17.

[Low doses of megestrol acetate increase weight and improve nutrition status in patients with severe chronic obstructive pulmonary disease and weight loss].

Herrejón A, Palop J, Inchaurraga I, López A, Bañuls C, Hernández A, Blanquer R, Están N, Anguera A.

Med Clin (Barc). 2011 Jul 23;137(5):193-8. doi: 10.1016/j.medcli.2011.02.016. Epub 2011 Apr 27. Spanish.

PMID:
21524765
18.

Megestrol acetate in cancer anorexia and weight loss.

Tchekmedyian NS, Hickman M, Siau J, Greco FA, Keller J, Browder H, Aisner J.

Cancer. 1992 Mar 1;69(5):1268-74.

PMID:
1739926
19.

Effectiveness of megestrol acetate in patients with advanced cancer: a randomized, double-blind, crossover study.

Bruera E, Ernst S, Hagen N, Spachynski K, Belzile M, Hanson J, Summers N, Brown B, Dulude H, Gallant G.

Cancer Prev Control. 1998 Apr;2(2):74-8.

PMID:
9765767
20.

Palliative treatment of cancer anorexia with oral suspension of megestrol acetate.

Tomíska M, Tomisková M, Salajka F, Adam Z, Vorlícek J.

Neoplasma. 2003;50(3):227-33.

PMID:
12937858
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk